Arkansas Medicaid as part of its System of Care review is considering expanding its coverage of cochlear implants to cover adults or individuals older than age 21. In support of this initiative, the Academy weighed in to support this effort. The Academy letter in support of this expansion provided that individuals who receive a cochlear implant generally increase their median income by $10,000–12,000 annually (Clinkard et al, 2015) and thereby reduce usage of state disability and welfare services.
Studies have shown that in states that provide this expanded coverage, the lifetime net gain is estimated at $400,000 per patient (Neve et al, 2021). In these ways, expanding coverage would produce a net economic gain for Arkansas. Expanding this coverage also would ensure that children who have received a cochlear implant in the Medicaid program would continue to be supported and receive the necessary accessories and updates after they turn 21.
References
Clinkard D, Barbic S, Amoodi H, Shipp D, Lin V. (2015) The economic and societal benefits of adult cochlear implantation: A pilot exploratory study. Cochlear Implants Int. (4):181–5. Doi:10.1179/17547622814Y.0000000096. Epub 2014 Sep 19. PMID: 25237848.
Neve OM, Boerman JA, van den Hout WB, Briaire JJ, van Benthem PPG, Frijns JHM. (2021) Cost-benefit analysis of cochlear implants: a societal perspective. Ear Hear. (5):1338–1350. Doi:10.1097/AUD.0000000000001021. PMID:33675588; PMCID: PMC8378541.
Recent Posts
How Do Animals Perceive Music?
Music can be defined as vocal, instrumental, or mechanical sounds, with rhythm, melody or harmony, and often, an expression of human emotion. Music can transcend…
‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely
Interesting research led by audiologist Ali Danesh, PhD, at Florida Atlantic University (FAU) helped develop a novel, proof-of-concept tool to help identify nystagmus using a…
Rizatriptan vs. Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial
Jeffrey Staab, MD, and colleagues studied the effectiveness of rizatriptan as a treatment option for vestibular migraine. Their research included 134 patients between the ages of…